Top

Surgical Endoscopy

Published in:

Open Access 01-03-2012

Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms

Authors: Karim S. Trad, Daniel G. Turgeon, Emir Deljkich

Published in: Surgical Endoscopy | Issue 3/2012

Abstract

Background

A retrospective study evaluated safety, symptom resolution, patient satisfaction, and medication use 1–2 years after transoral incisionless fundoplication (TIF) in patients with gastroesophageal reflux disease (GERD) and/or laryngopharyngeal reflux (LPR) symptoms.

Methods

Thirty-four patients with a confirmed diagnosis of GERD symptoms that were inadequately controlled by antisecretory medications, and who where either dissatisfied with their current therapy or not willing to continue taking medication, underwent TIF using EsophyX at our community-based hospital. Follow-up assessments were completed in 28 patients.

Results

Median age of the study group was 57 (range = 23–77) years, BMI was 25.7 (18.3–36.4) kg/m², and 50% were female. All patients had documented chronic GERD for a median 5 (1–20) years and refractory symptoms to proton pump inhibitors (PPIs). Hiatal hernia was present in 75% (21/28) of patients, and 21% (6/28) had erosive esophagitis (LA grade A or B). TIF was performed following a standardized TIF-2 protocol and resulted in reducing hiatal hernia and restoring the natural anatomy of the gastroesophageal (GE) junction (Hill grade I). There were no postoperative complications. At a median 14-months follow-up, 82% (23/28) of patients were off daily PPIs (64% completely off PPIs), and 68% (19/28) were satisfied with their current health condition compared to 4% before TIF. Median GERD Health-Related Quality of Life scores were significantly reduced to 4 (0–25) from 26 (0–45) before TIF (P < 0.001). Heartburn was eliminated in 65% (17/26) and improved by >50% in 86% (24/28) of patients. Regurgitation was eliminated in 80% (16/20) of patients. Atypical LPR symptoms such as hoarseness, coughing, and throat clearing were eliminated in 63% (17/27) of patients as measured by Reflux Symptom Index scores.

Conclusion

Our results in 28 patients confirm the safety and effectiveness of TIF, documenting symptomatic improvement of GERD and LPR symptoms and clinically significant discontinuation of daily PPIs in 82% of patients.

Dallemagne B, Weerts JM, Jehaes C, Markiewicz S, Lombard R (1991) Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc 1(3):138–143PubMed

Tsimogiannis KE, Pappas-Gogos GK, Benetatos N, Tsironis D, Farantos C, Tsimoyiannis EC (2009) Laparoscopic Nissen fundoplication combined with posterior gastropexy in surgical treatment of GERD. Surg Endosc 24:1303–1309PubMedCrossRef

Finks JF, Wei Y, Birkmeyer JD (2006) The rise and fall of antireflux surgery in the United States. Surg Endosc 20:1698–1701PubMedCrossRef

Funch-Jensen P, Bendixen A, Iversen MG, Kehlet H (2008) Complications and frequency of redo antireflux surgery in Denmark: a nationwide study, 1997–2005. Surg Endosc 22:627–630PubMedCrossRef

Hahnloser D, Schumacher M, Cavin R, Cosendey B, Petropoulos P (2002) Risk factors for complications of laparoscopic Nissen fundoplication. Surg Endosc 16:43–47PubMedCrossRef

Hunter JG, Swanstrom L, Waring JP (1996) Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg 224:51–57PubMedCrossRef

Lundell L (2004) Complications after anti-reflux surgery. Best Pract Res Clin Gastroenterol 18:935–945PubMed

Fass R (2007) Proton-pump inhibitor therapy in patients with gastro-oesophageal reflux disease: putative mechanisms of failure. Drugs 67:1521–1530PubMedCrossRef

Lu M, Malladi V, Agha A, Abydayyeh S, Han C, Siepman N, Graham DY (2007) Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci 2052:2813–2820CrossRef

10.

Kahrilas PJ, Howden CW, Hughes N (2011) Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease. Am J Gastroenterol 106(8):1419–1425PubMedCrossRef

11.

Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448–1456PubMedCrossRef

12.

Hewson EG, Sinclair JW, Dalton CB, Richter JE (1991) Twenty-four hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain. Am J Med 90:576–583PubMed

13.

Madan AK, Ternovits CA, Tichansky DS (2006) Emerging endoluminal therapies for gastroesophageal reflux disease: adverse events. Am J Surg 192:72–75PubMedCrossRef

14.

Bell RC, Freeman KD (2011) Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Surg Endosc 25(6):1975–1984PubMedCrossRef

15.

Barnes WE, Hoddinott KM, Mundy S, Williams M (2011) Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov 18(2):119–129PubMedCrossRef

16.

American Society of General Surgeons (2009) ASGS Position Statement on Natural Orifice Surgery and Transoral Incisionless Fundoplication. Available at www.theasgs.org. Accessed 9 Aug 2011

17.

Society of American Gastrointestinal and Endoscopic Surgeons (2009) SAGES Position Statement on Endoluminal Therapies for Gastrointestinal Diseases. Available at www.sages.org/publication/id/ENDOL. Accessed 9 Aug 2011

18.

Jobe BA, Kahrilas PJ, Vernon AH, Sandone C, Gopal DV, Swanstrom LL, Aye RW, Hill LD, Hunter JG (2004) Endoscopic appraisal of the gastroesophageal valve after antireflux surgery. Am J Gastroenterol 99:233–243PubMedCrossRef

19.

Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130–134PubMedCrossRef

20.

Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA (1996) Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg 183:217–224PubMed

21.

Allen JC, Parameswaran K, Belda J, Anvari M (2000) Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 13:265–270PubMedCrossRef

22.

Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2006) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 13:238–249PubMedCrossRef

23.

Belafsky PC, Postma GN, Koufman JA (2002) Validity and reliability of the reflux symptom index (RSI). J Voice 16(2):274–279PubMedCrossRef

24.

Cadiere GB, Buset M, Muls V, Rajan A, Rosch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Deviere J (2008) Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg 32:1676–1688PubMedCrossRef

25.

Cadiere GB, Van Sante N, Graves JE, Gawlicka AK, Rajan A (2009) Two-year results of a feasibility study on antireflux transoral incisionless fundoplication (TIF) using EsophyX. Surg Endosc 23:957–964PubMedCrossRef

26.

Hunter JG, Trus TL, Branum GD, Waring JP, Wood WC (1996) A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 223:673–685PubMedCrossRef

27.

Sala E, Salminen P, Simberg S, Koskenvuo J, Ovaska J (2008) Laryngopharyngeal reflux disease treated with laparoscopic fundoplication. Dig Dis Sci 53:2397–2404PubMedCrossRef

28.

Walker SJ, Holt S, Sanderson CJ, Stoddard CJ (1992) Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-oesophgeal reflux. Br J Surg 79:410–414PubMedCrossRef

29.

Westcott CJ, Hopkins MB, Bach K, Postma GN, Belafsky PC, Koufman JA (2004) Fundoplication for laryngopharyngeal reflux disease. J Am Coll Surg 199:23–30PubMedCrossRef

30.

Jobe BA, O’Rourke RW, McMahon BP, Gravesen F, Lorenzo C, Hunter JG, Bronner M, Kraemer SJ (2008) Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg 248:69–76PubMedCrossRef

31.

Patti MG, Arcerito M, Tamburini A, Diener U, Feo CV, Safadi B, Fisichella P, Way LW (2000) Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms. J Gastrointest Surg 4:143–149PubMedCrossRef

32.

So JB, Zeitels SM, Rattner DW (1998) Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 124:28–32PubMedCrossRef

33.

Wetscher GJ, Glaser K, Hinder RA, Perdikis G, Klingler P, Bammer T, Wieschemeyer T, Schwab G, Klingler A, Pointner R (1997) Respiratory symptoms in patients with gastroesophageal reflux disease following medical therapy and following antireflux surgery. Am J Surg 174:639–643PubMedCrossRef

Title: Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms
Authors: Karim S. Trad
Daniel G. Turgeon
Emir Deljkich
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 3/2012
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-011-1932-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

U-clip for airway reconstruction: an experimental study of the feasibility of a robot-assisted endoscopic procedure

Risk factors for pancreatitis following transpapillary self-expandable metal stent placement

Combined pretherapeutic endoscopic and laparoscopic ultrasonography may predict survival of patients with upper gastrointestinal tract cancer

Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion

α-Defensins and hsCRP levels in inflammatory response of standard and laparoendoscopic single-site cholecystectomy

The world is getting smaller